Feasibility of Adapted Physical Activity Based on a Walking Platform in Hospitalized Old Patients for Cancer

Oncology Clinical Trial

— APPAHOCA  

Official title:

Feasibility of Adapted Physical Activity Based on a Walking Platform in Hospitalized Old Patients for Cancer

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03473652
• Other study ID #: APPAHOCA
• Status: Completed
• Phase: N/A
• Start date: May 29, 2018
• Est. completion date: December 11, 2018

Study information

• Verified date: March 2018
• Source: Centre Francois Baclesse
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigator propose to evaluate the interest of the provision of a suitable treadmill offering fall protection and verticalization assistance.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: December 11, 2018
• Est. primary completion date: October 11, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 70 Years and older

Eligibility

Inclusion Criteria:

• Patient with cancer

• Patient over 70 years old hospitalized 48 hours or more

• Patient identified as eligible for medical prescription of Adapted physical activity

• Mastery of the French language ;

• Patient affiliated to a social security scheme

• Patient giving written consent

Exclusion Criteria:

• Patient totally unable to communicate

• Patient in terminal palliative care

• Patient with a size <1m35 or> 2m and / or a weight> 130kg

• Patient unable to perform Adapted physical activity sessions

• Patient unable to wear a restraint harness.

• Patient deprived of liberty or under guardianship

• Patient unable to comply with protocol requirements for geographical, social or psychopathological reasons

Related Conditions & MeSH terms

• Adapted Physical Activity
• Oncology

Intervention

Other:
• Adapted walking platform
The walking sessions will be carried out on a suitable walking platform, including a connected play tablet.

Locations

Country	Name	City	State
France	Centre François Baclesse	Caen
France	CHU	Caen

Sponsors (1)

Lead Sponsor	Collaborator
Centre Francois Baclesse

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient adherence to use a walking Platform	Adapted physical activity on a walking platform will be considered feasible if > or = to 70% of patients perform > or = to 2 sessions of 6 minutes or more during hospitalization for cancer lasting > or = to 48h	2 days